ABSTRACT Fibroblast growth factor 21 (FGF21) serves as an essential biomarker for early detection and diagnosis of nonalcoholic fatty liver disease (NAFLD). It has received a great deal of attention recently in efforts to develop an accurate and effective method for detecting low levels of FGF21 in complex biological settings. Herein, we demonstrate a label-free, simple and high-sensitive field-effect transistor (FET) biosensor for FGF21 detection in a nonaqueous environment, directly utilizing two-dimensional molybdenum disulfide (MoS 2 ) without additional absorption layers. By immobilizing anti-FGF21 on MoS 2 surface, this biosensor can achieve the detection of trace FGF21 at less than 10 fg mL −1 . High consistency and satisfactory reproducibility were demonstrated through multiple sets of parallel experiments for the MoS 2 FETs. Furthermore, the biosensor has great sensitivity to detect the target FGF21 in complex serum samples, which demonstrates its great potential application in disease diagnosis of NAFLD. Overall, this study shows that thin-layered transition-metal dichalcogenides (TMDs) can be used as a potential alternative platform for developing novel electrical biosensors with high sensitivity and selectivity.
INTRODUCTION
With the rapid lifestyle, diet and habit changes, nonalcoholic fatty liver disease (NAFLD) has becoming a significant risk factor as one of the major chronic liver diseases in developed countries such as Europe, the United States and in rich areas of China [1] . The NAFLD occurrence in general adults is 10% to 30%, and it has become a major cause of liver diseases which can progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC) [2, 3] . The detection of biomarkers at the earliest stage is of great significance to NAFLD diagnostics. A new metabolic regulator, fibroblast growth factor 21 (FGF21), has decisive effects on lowering blood glucose, lipids and insulin levels, reversing hepatic steatosis, and increasing insulin sensitivity [4, 5] . Previous studies have shown that FGF21 plays a crucial role in liver metabolism and serves as a potential NAFLD marker. The level of FGF21 in blood plasma is an important indicator for patients with NAFLD [6] . At this stage, the method for detecting FGF21 by enzyme-linked immunosorbent assay (ELISA) is highly selective and commonly practiced; however, this method has some critical disadvantages such as complicated sample processing, high cost, limited applications in real-time monitoring, and low detection sensitivity [7, 8] . Hence, developing robust assay platforms to enable an accurate and efficient detection of low-level FGF21 in complex biological samples is still a challenging topic.
In recent years, field-effect transistors (FETs) have been proposed as one of the most promising electrical technologies for rapid biomolecule detection due to their label-free, in-situ detection capabilities, and high sensitivity [9, 10] . One-dimensional (1D) semiconductors, such as silicon nanowires (SiNWs) [11, 12] and carbon nanotubes (CNTs) are used for FET biosensors, which can improve the sensitivity due to high switching characteristics (high current switching ratio) and excellent surface chemistry efficiency [13, 14] ; however, there are some limitations such as the lack of practical applications due to device-todevice deviation and relatively high cost in large-scale manufacturing [10] . Compared to 1D nanostructures, two-dimensional (2D) materials have larger specific surface area leading to greater sensitivity for target molecules, and better scalability which facilitates large-scale fabrication; thus these advantages and superior performances call for the constructions of highly effective and efficient FET biosensors [15] [16] [17] . Nevertheless, due to the absence of band gap structure, the use of graphene and its derivatives as conductive materials in FET biosensors, results in a low switch of FET, which limits the detection sensitivity of the sensor [18] [19] [20] . Molybdenum disulfide (MoS 2 ), on the other hand, a typical semiconducting layered transition-metal dichalcogenide (TMD), has attracted increasing attention on the basis of its tunable band gap structure compared with graphene [21, 22] . It has a layer-dependent electronic band structure with excellent electrical, physical, optical and catalytic properties, which are desirable in developing new generations of electronics and optoelectronic devices [23] [24] [25] . Meanwhile, MoS 2 shows high stability in air due to a lack of dangling bonds, which significantly improves the performance of FETs for biosensing [26] . Recent reports have demonstrated MoS 2 FETs were used for electrical detection of various biomolecules. Park et al. [27] investigated the FET device using multi-layered MoS 2 with alumina (Al 2 O 3 ) as a protective layer for detecting prostate specific antigen (PSA) to achieve high sensitivity, with a limit of 100 fg mL −1 . Lee et al. [28] 
MoS 2 FET fabrication
Thin layers of MoS 2 nanosheets were mechanically exfoliated from natural bulk materials using scotch tape and transferred on highly p-doped Si substrate with 300 nm SiO 2 . The thickness of the multilayer MoS 2 flakes was determined by optical and atomic force microscopy (AFM). MoS 2 flakes with thickness in the range of 5-15 nm were used to fabricate the field-effect transistors. The channel length of our device was 10 μm according to the size of TEM-grid used as the mask, and then In/Au (5 nm/50 nm) electrodes were deposited as the source and drain electrodes (S/D) on MoS 2 by thermal evaporation, respectively. We used back gate FET to detect the biointeraction in dry states, and the voltage was added through the back Si. To reduce the contact resistance, MoS 2 FETs were annealed at 200°C for 1 h with 100 sccm of Ar and 10 sccm of H 2 under atmospheric pressure.
Surface functionalization and biosensing process
The devices were incubated for 2 h with 5 mmol L −1 PASE solution, which was composed of DMF dissolved at room temperature, washed with deionized (DI) water and blow-dried with nitrogen (N 2 ). Anti-FGF21 was dissolved in PBS (1×, 0.01 mol L −1 ) solution (pH 7.2-7.4) at a concentration of 50 μg mL −1 . The device was placed in a 4°C refrigerator overnight in order to immobilize the anti-FGF21 and then rinsed with DI water. BSA (50 μg mL −1 ) was used for 1 h as a blocking agent to reduce the non-specific adsorption. After being rinsed, the device was incubated at room temperature for 30 min with different concentrations of FGF21 solution from 10 fg mL −1 to 1 ng mL −1 , rinsed with DI water and dried with N 2 . Serum samples were 10-fold-diluted directly without additional treatment. The concentration of FGF21 in human serum samples was increased from 10 fg mL
to 1 ng mL −1 . The FET was measured in dry state.
Device measurement and characterization
The optical image was obtained by Nikon H600L microscopy. The electrical transport and sensing behavior were measured with a probe station (Cascade Microtech, MPS 150) connected with Keithley Sourcemeter 2634B at room temperature under ambient conditions. AFM characterization was conducted using Bruker Dimension Icon.
RESULTS AND DISCUSSION
Working principle and characterization of MoS 2 nanosheets Fig. 1a shows the schematic of the MoS 2 FET surface functionalization that immobilized anti-FGF21 and its interaction with FGF21. The FET channel surface was directly functionalized with PASE by van der Waals interaction between the MoS 2 surface and the pyrene group [30] . Then, anti-FGF21 was tightly immobilized onto the terminal amino group of PASE via a covalent bond. Finally, BSA was introduced as a blocking agent to prevent non-specific adsorption of antibody. We chose PASE as a linker molecule to directly modify the surface of pristine MoS 2 , which simplified the procedure, and more importantly, strongly immobilized the biomolecules via van der Waals force, improving the electronic transmission performance and achieving higher selectivity than physical adsorption [31] . The typical structure of the FET biosensor with a multilayer MoS 2 as semiconducting channel is illustrated in Fig. 1b . Briefly, pristine MoS 2 FETs were fabricated by mechanical exfoliation from natural bulk materials. Optical microscopy and AFM enable us to feasibly identify the number of layers [32] . In order to improve the reproducibility of the MoS 2 FET, and achieve higher sensitivity without being affected by other interference factors, the MoS 2 with thickness in the range of 5-15 nm was selected to construct the devices. Meanwhile, contact resistance arising from the metal-semiconductor plays a key role in affecting the transistor performance [10] . Gold (Au), and indium (In) have been proved to make highquality ohmic contact for fabricating high-performance MoS 2 transistors. Firstly, the work function of In (about 4.12 eV) is smaller than that of the n-type MoS 2 (in the range of 4.6-4.9 eV) [33] . Thus, the electron carrier ac- cumulates at the In-MoS 2 interface, and no barrier exists for the electron carrier. Secondly, In and MoS 2 can form van der Waals interaction to demonstrate a low contact resistance and provide good contact, as reported in a recent study [34] . Here, 5 nm In followed by 50 nm Au were deposited as the source and drain electrodes, which can maintain the higher mobility for biosensor and also increase the adhesion force compared with gold electrodes. To demonstrate the stability of In in 1×PBS solution, we measured the electrical properties before and after treatment of the device in 1×PBS as control, and the device showed negligible current change in transfer characteristics, as shown in Fig. S1 .
The electrical properties of MoS 2 FETs were characterized by measuring the transfer curve (i.e., drainsource current versus gate voltage, I D −V GS ) and the output curve (i.e., drain-source current versus drain voltage, conditions [35] .
To demonstrate the immobilization of anti-FGF21 and its specific reactivity with FGF21 on MoS 2 FETs through the PASE treatment, AFM was used to characterize the surface morphology. Fig. 2a shows that the root-meansquare (R q ) roughness of the pristine MoS 2 is 0.386 nm prior to treatment. AFM images of the modified MoS 2 , i) after immobilized with anti-FGF21 and ii) after its complexation with FGF21 are shown in Fig. 2b , c, respectively. Compared with the anti-FGF21 functionalization (R q = 0.770 nm), Fig. 2c exhibits an increased value to 1.15 nm, suggesting that anti-FGF21 structure specifically bound with FGF21 after the treatment.
Electrical properties of MoS 2 FET device
In order to further verify the immobilization of antibodies, electrical responses were characterized. As shown in Fig. 3a , the current increases after the immobilization of anti-FGF21. Considering the correlation between the binding molecule and the charge distribution on MoS 2 channel, it is well-known based on the 'pH memory theory' that when the protein is dried, its ionization state in aqueous solution (1×PBS) pH is retained, and thus the chargeability remains unchanged [36, 37] . Therefore, the current increase indicated that the antibody was a positive charged molecule without necessarily knowing the isoelectric point (pI) of the anti-FGF21. In order to verify the chargeability of the antibody, we directly immobilized BSA and FGF21 through the PASE molecule on the surface of pristine MoS 2 , which was consistent with the conditions for immobilized anti-FGF21. As shown in Fig. 3b and c, both of the currents reduced after fixing FGF21 and BSA. The pIs of FGF21 and BSA are about 5.43 and 4.7, respectively. According to the 'pH memory theory', the pH of PBS ranging from 7.2 to 7.4 was higher than the pIs of the two proteins, leading to the negative potential of FGF21 and BSA. The negatively charged BSA and FGF21 were immobilized on the n-type MoS 2 channel, which reduced the effective gate field under positive gate bias conditions, thereby reducing the density of accumulated electrons to reduce I D . Hence, it was demonstrated that anti-FGF21 was a positive charged molecule. After knowing the chargeability of anti-FGF21, BSA and FGF21, we took a step-by-step observation of their current responses on another device. Fig. S3 shows the anti-FGF21 fixation led to an increase in current, consistent with the result in Fig. 3a . After BSA immobilization, the current decrease was negligible, the results indicated that most binding sites were already occupied by FGF21 antibody and just a small fraction of sites were available on the MoS 2 surface. The inevitable interference as a blocker can be ignored although BSA is negatively charged. After FGF21 was specifically combined with ant-FGF21, the current further decreased. This process can provide experimental evidence for the consecutive trends of current change caused by the FGF21 concentration gradients. The 'pH memory theory' can be utilized as an excellent theoretical basis for achieving highly accurate and reproducible biosensor operation [27] .
After investigating the sensing behavior of MoS 2 transistor, the sensing mechanism behind the change of the current is further discussed. For example, a change of doping effect (charge transfer) can result in a shift of the threshold voltage (V th ) in transfer characteristic and change the current at any gate voltage, and changes in carrier mobility will lead to corresponding changes in the slope of the transfer characteristic transconductance [38, 39] . In Fig. S3 , after positively charged anti-FGF21 molecules were adsorbed, the threshold voltage in the transfer curve changed from 24.6 to 13.45 V, resulting in a negative shift, which indicated an obvious n-doping effect [40] . This effect implies that electrons in the molecule are transferred to MoS 2 . The negatively charged FGF21 specifically bound to partial antibody and V th changed from 13.45 to 20.79 V. Since it reduces the effect of antibodies on the surface conductivity of the MoS 2 , it is equivalent to the effect of p-doping. Thereby, the amount of electron transfer in the molecule to MoS 2 is reduced, resulting in a V th shifting in the positive direction relative to the antibody, while incomplete capture of the antibody results in its V th being shifted to a negative direction relative to the original current. The variation of the V th in different doping processes is consistent with the 'pH memory theory'.
Sensitivity of FET biosensor
Electrical measurements of anti-FGF21 binding with target FGF21 were performed on the MoS 2 channel based FETs. Fig. S4 shows that FGF21 incubation reaches equilibrium after 30 min, therefore, a 30-min incubation time was adopted for all the consecutive treatment. Under the same reaction conditions, Fig. 4a shows the transfer characteristics of the same MoS 2 FET device measured at incremental concentrations of FGF21: 10 fg mL −1 , 100 fg mL
, 1 pg mL
, 10 pg mL
, 100 pg mL −1 and 1 ng mL −1 . According to 'pH memory theory', anti-FGF21 retains its original chargeability during FGF21 repeated incubations. The current decreases gradually with increasing FGF21 concentration in the I D −V GS transfer curves, and it can be clearly seen that the current greatly varies at the concentration of 10 fg mL
. Sensitivity was determined by the absolute value of the fractional change of the I D at V GS = 60 V, against the logarithmic change of the concentrations (Fig. 4c) . The fractional change in current clearly indicates a quantitative relationship in which the current decreases as the concentration of FGF21 increases from 10 fg mL −1 to 1 ng mL
. Meanwhile, Fig. S5 shows the V th shift at different concentrations of FGF21. The V th change enhanced stepwise with FGF21 concentration increasing, which indicated that the doping effect also increased. Normally, the level of FGF21 in healthy human is in range of 45.3 to 66.7 pg mL −1 [8, 41] . This biological range is well within our device testing range. Therefore, the MoS 2 FETs demonstrated here exhibit high sensitivity and response at a low concentration of 10 fg mL −1 with a standard error under 3%, which also lay the foundation for rapid detection reactions and biosensing. As shown in Fig. S6 , an additional parallel experiment using four sets of FGF21 concentration gradients produced similar results as those in Fig. 4 , i.e., large responses for FGF21 concentrations as low as 10 fg mL −1 and having the same trend of current change.
For FET-based biosensors, device-to-device diversity is the main challenge for their practical applications. The change in each step and batch will affect the response of the device detection, such as the thickness, the defect of the materials, the details of the fabrication, the contact between metal and semiconductors and the detection measurement condition. For MoS 2 FET biosensor, functionalization of MoS 2 is also an important process for the interactions between these 2D materials and biomolecules. In a nonaqueous environment of our experiment, there is less interference of Debye length [27] . 
Selectivity of FET biosensor
To test the selectivity of the prepared MoS 2 FET biosensor, we chose several proteins, including IL-6, CRP and MB, as potential interferences. It has been reported that NAFLD is not only an early marker of insulin resistance but also an early indication of atherosclerosis, which is positively related to inflammation. In fact, patients identified with NAFLD significantly increase their chance of getting cardiovascular diseases (CVDs). When people have inflammation, IL-6 and CRP will increase in blood, while MB is also another commonly present protein. The MoS 2 FETs with immobilized anti-FGF21 have non-specifically bound to 10 ng mL high selectivity.
Serum sample analysis
To further investigate the practical application of the proposed MoS 2 FET biosensors, we added FGF21 to healthy human serum for measurement. The serum sample was diluted 10-fold, and then different concentrations of FGF21 (i.e., 10 fg mL −1 , 100 fg mL −1 , 1 pg mL −1 , 10 pg mL −1 , 100 pg mL −1 and 1 ng mL −1 ) were added into the serum, and measured with 5 different devices under same conditions, 10-fold-diluted serum sample without any treatment was used as a control ( Fig. 4b and Fig. S8 ). As shown in Fig. 4b , the biosensor still maintained a high detection capacity in serum, i.e., high current response at 10 fg mL −1 FGF21 concentration. 
CONCLUSION
In conclusion, we have developed a reproducible MoS 2 FET biosensor capable of detecting FGF21 with high sensitivity and selectivity. The proposed MoS 2 FET biosensor relies on simple surface treatment to directly bind the antibody after a modified linker. This FET biosensor showed high sensitivity with a detection limit of 10 fg mL −1 (with a standard error under 3%), and in this condition, obvious current change was still observed. So we supposed that the sensor could detect trace FGF21 at concentrations lower than 10 fg mL −1 . Furthermore, the biosensor is also capable of detecting target FGF21 in serum, and shows great selectivity with the presence of several potential interference proteins. The lowest detectable concentration in serum is 10 fg mL −1 , similar to the value measured in the buffer solution. This highly sensitive and selective MoS 2 FET biosensor illustrates a promising approach to detect FGF21 in real serum, offering an important mean of early diagnosis of NAFLD. It opens new doors to utilize layered 2D materials in pointof-care diagnostic devices, for both specific biological event detection and real-time measurements.
